Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cerulean Pharma Inc.
ClinicalTrials.gov Identifier:
NCT00333502
First received: June 1, 2006
Last updated: July 30, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)